MarketPeel
Insider Trading Intelligence
MZ

Mai-britt Zocca

IOBT
CHIEF EXECUTIVE OFFICER · IO BIOTECH, INC. · CIK 0001890736
FILING MIX · LIFETIME89%/11%
BUYS
8
SELLS
1
TOTAL VALUE
$85.1K
COMPANIES
1
ACTIVE SINCE
Nov 2021
HOLDINGS NOW
580,000
AVG SELL PX
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Mai-britt Zocca, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+5.90%-1.09%+6.99%+6.99%
14d1+100.00%+0.97%+0.11%+0.85%+0.85%
30d1+100.00%+1.18%+1.98%-0.80%-0.80%
60d1+100.00%+23.65%+0.88%+22.77%+22.77%
90d1+100.00%+12.41%-3.17%+15.59%+15.59%
180d1+100.00%+46.13%+0.23%+45.90%+45.90%
1y1+0.00%-21.31%+16.03%-37.34%-37.34%
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IOBT · 580,000 shares · as of Apr 2, 2025
0187,500375,000562,500750,0002022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
FLOW · 8 buys / 1 sellsCOVERAGE · 15 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IOBT
IO BIOTECH, INC.
PURCHASEGRANT
Stock grant
580,000580,000Apr 2, 2025Apr 4, 2025View →
IOBT
IO BIOTECH, INC.
PURCHASE
Chief Executive Officer
12,500$0.81$10.1K49,891Dec 23, 2024Dec 23, 2024View →
IOBT
IO BIOTECH, INC.
PURCHASEGRANT
Stock grant
750,000750,000Mar 15, 2024Mar 18, 2024View →
IOBT
IO BIOTECH, INC.
PURCHASEGRANT
Stock grant
37,037$0.13$4.6K37,037Aug 9, 2023Aug 9, 2023View →
IOBT
IO BIOTECH, INC.
PURCHASEGRANT
Stock grant
37,037$1.90$70.4K37,391Aug 9, 2023Aug 9, 2023View →
IOBT
IO BIOTECH, INC.
PURCHASEGRANT
Stock grant
500,000500,000Mar 20, 2023Mar 22, 2023View →
IOBT
IO BIOTECH, INC.
PURCHASE
Chief Executive Officer
26,58026,580Nov 9, 2021Nov 12, 2021View →
IOBT
IO BIOTECH, INC.
SALE
Chief Executive Officer
26,5800Nov 9, 2021Nov 12, 2021View →
IOBT
IO BIOTECH, INC.
PURCHASEGRANT
Stock grant
414,212414,212Nov 4, 2021Nov 8, 2021View →
Other insiders · IOBT
Loading peer insiders…
About this filer
CIK 0001890736
ROLE
Chief Executive Officer
PRIMARY
IOBT
COMPANIES
1
ACTIVE SINCE
Nov 2021
MARKETPEEL · /INSIDER/0001890736DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback